Nanotechnology Now

Heifer International

Wikipedia Affiliate Button


Home > Press > Nanoink appoints Dean Hart executive vice president commercial operations

NanoInk, Inc. announced today the appointment of Dean Hart, as its executive vice president of commercial operations.

Nanoink appoints Dean Hart executive vice president commercial operations

SKOKIE, IL | Posted on February 19th, 2008

"We are extremely pleased that Dean has joined the NanoInk team," said Jim Hussey, CEO of NanoInk. "His track record of success and commercial experience will be important to our plans for both Brand Protection and Dip Pen Nanolithography businesses."

Mr. Hart joins NanoInk from Vision Point of Sale, Inc., a leading point-of-sale equipment and services company located in Glenview, Ill., where he served as vice president of sales and marketing during the past two years.

Prior to joining Vision Point of Sale, Mr. Hart served as senior vice president of sales at Takeda Pharmaceuticals North America, Inc., a Deerfield, Ill.-based U.S. subsidiary of Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company. At Takeda, he was instrumental in the success of Takeda's flagship diabetes product and market leader, ACTOS®, and led the growth of Takeda's sales force to support the launch of two new products in the diabetes and sleep market.

Previously, Mr. Hart served as president of Sequest Technologies, where he successfully established a market presence for the Oakbrook, Ill. software company in the health care technology field.

Mr. Hart began his career in sales, marketing and sales management at Bristol-Myers Squibb where he held positions of increased responsibility up to and including his appointment to associate director regional operations in 1994. He became the national sales director for the U.S. subsidiary of the Japanese pharmaceutical company Eisai, Inc. in 1996. At Eisai, Mr. Hart built the sales organization and successfully launched Eisai's first product in the U.S. pharmaceutical marketplace, Aricept®, the most prescribed drug in the world for the treatment of Alzheimer's.

Mr. Hart holds a B.S. in Business Management from Indiana University and a Masters of Business Administration from the Kellogg School of Management at Northwestern University.


About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the lifescience and semiconductor industries. With DPN, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology.

For more information, please click here

David Gutierrez
Dresner Corporate Services

Joshua Taustein
Dresner Corporate Services

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Discovery of nanotubes offers new clues about cell-to-cell communication July 2nd, 2015

Nanospiked bacteria are the brightest hard X-ray emitters July 2nd, 2015

Engineering the world’s smallest nanocrystal July 2nd, 2015

Producing spin-entangled electrons July 2nd, 2015


Iranian Scientists Find Simple, Economic Method to Synthesize Antibacterial Nanoparticles July 2nd, 2015

Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015

Carnegie Mellon chemists characterize 3-D macroporous hydrogels: Methods will allow researchers to develop new 'smart' materials June 30th, 2015

Chitosan coated, chemotherapy packed nanoparticles may target cancer stem cells June 30th, 2015


Nanospiked bacteria are the brightest hard X-ray emitters July 2nd, 2015

Engineering the world’s smallest nanocrystal July 2nd, 2015

Producing spin-entangled electrons July 2nd, 2015

NIST Group Maps Distribution of Carbon Nanotubes in Composite Materials July 2nd, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Angstron Materials Appoints VP for Business Development And Engineering June 27th, 2015

Solegear Further Strengthens its Product Development Team: New Hire Seeks to Create New, Disruptive, Sustainable Materials June 17th, 2015

Janusz Bryzek Joins MEMS Industry Group to Lead New TSensors Division - New Division will Focus on Accelerating Development of Emerging Ultra-high Volume Sensors Supporting Abundance, mHealth and IoT May 14th, 2015

Carbodeon Appoints Leading Industry Expert as Advisory Board Member May 7th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project